Augmentation of tumor expression of HLA-DR, CXCL9, and CXCL10 may improve olfactory neuroblastoma immunotherapeutic responses.

Saved in:
Bibliographic Details
Title: Augmentation of tumor expression of HLA-DR, CXCL9, and CXCL10 may improve olfactory neuroblastoma immunotherapeutic responses.
Authors: Larkin, Riley M.1,2 (AUTHOR), Lopez, Diana C.1,3 (AUTHOR), Robbins, Yvette L.4 (AUTHOR), Lassoued, Wiem5 (AUTHOR), Canubas, Kenneth5 (AUTHOR), Warner, Andrew6 (AUTHOR), Karim, Baktiar6 (AUTHOR), Vulikh, Ksenia6 (AUTHOR), Hodge, James W.5 (AUTHOR), Floudas, Charalampos S.5 (AUTHOR), Gulley, James L.5 (AUTHOR), Gallia, Gary L.3,7 (AUTHOR), Allen, Clint T.4 (AUTHOR), London Jr., Nyall R.1,3,7 (AUTHOR) nyall.london@nih.gov
Source: Journal of Translational Medicine. 5/31/2024, Vol. 22 Issue 1, p1-16. 16p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14795876
DOI:10.1186/s12967-024-05339-9